Reckitt's Mead Johnson Wins First Federal Infant Formula Bellwether Trial
A federal jury ruled in favor of Reckitt Benckiser's Mead Johnson unit in the first bellwether trial over allegations that its infant formula for premature babies is linked to a deadly bowel disease.
The case is part of a federal multidistrict litigation comprising lawsuits accusing the product of causing the illness.


